Contact Us
Investor/Media Information
View contact details for Investor Relations and Media Relations representatives.
U.S. Adverse Event Reporting
If you experience an adverse event (side effect) with the administration or use of any Elan product, contact your healthcare provider immediately.
For reports of adverse events (side effects) possibly associated with the use of TYSABRI® (natalizumab), which is being developed and marketed by Elan in collaboration with Biogen Idec, please contact Biogen Idec at 1-800-456-2255.
Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding PRIALT® (ziconitide intrathecal infusion), please contact Azur Pharma at 1-888-PRI-ALT1 or by e-mail at MedicalAffairs@azurpharma.com.
Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding MAXIPIME® (cefepime hydrochloride, USP) for Injection or AZACTAM® (aztreonam for injection, USP), please contact Bristol Myers Squibb Medical Information (BMS) at 1-800-321-1335 or by email at Drug.Information@bms.com.
Locations
Headquarters
Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland
TEL (353) 1 709 4000, FAX (353) 1 709 4700
180 Oyster Point Boulevard, South San Francisco, CA 94080
TEL (650) 877 0900, FAX (650) 877 7669
Your feedback is helpful in determining the types of information you would be interested in seeing. Please submit your feedback to website.feedback@elan.com. Do not use the feedback e-mail address to report adverse events (side effects). Please see the Adverse Event Reporting section above.
U.S. Healthcare Professionals
Medical Information Services
For Medical Information, please click here
Careers/Job Opportunities
Search for a job with Elan.